Sopharma AD Logo

Sopharma AD

Pharmaceutical producer of Rx, OTC, and plant-based medicines for international markets.

SFA | BSOBGN

Overview

Corporate Details

ISIN(s):
BG11SOSOBT18
LEI:
097900BGGW0000048796
Country:
Bulgaria
Address:
ул. Лъчезар Станчев 5, кула А, ет.18, 1756 София

Description

Sopharma AD is a pharmaceutical company founded in 1933 that specializes in the production, distribution, and export of a wide range of medical products. The company's portfolio includes prescription (Rx) and over-the-counter (OTC) medicines, encompassing both branded and generic drugs. A key area of focus is its traditional plant-based products. Sopharma develops treatments for various conditions, including liver disease, pain management, and smoking cessation. Operating from EU-GMP certified facilities, the company also provides contract manufacturing services and has an established presence in over 40 international markets.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2017-09-21 13:11
Notification for acquisition of own shares 20 September 2017
Polish 34.5 KB
2017-09-21 10:10
Current report 91 re insiders transactions -Doneva
Polish 50.0 KB
2017-09-20 13:16
Notification
Polish 25.5 KB
2017-09-20 09:15
NOTIFICATION OF INSIDERS’ TRANSACTIONS
Polish 49.0 KB
2017-09-19 15:59
Current report 88 re insiders transactions -Donev
Polish 48.5 KB
2017-09-19 13:43
Current report 87 re insiders transactions
Polish 56.5 KB
2017-09-19 13:38
Notification
Polish 26.5 KB
2017-09-19 13:15
Notification for acquisition of own shares
Polish 35.0 KB
2017-09-18 16:46
Notification for treasury shares from 15.09.2017
Polish 34.5 KB
2017-09-15 16:08
Current report 83 re insiders transactions - Elpharma
Polish 45.5 KB
2017-09-15 16:02
Acquisition of own shares from 12.09.2017 up to including 14.09.2017
Polish 34.5 KB
2017-09-15 09:34
Current report 81 re insiders transactions -Doneva
Polish 50.5 KB
2017-09-15 09:10
Current report 80 re insiders transactions -Donev
Polish 47.5 KB
2017-09-15 08:50
Current report 79 re insiders transactions - DIH
Polish 56.5 KB
2017-09-14 13:19
Notification for s signed contract for transformation through merger of Uniphar…
Polish 42.0 KB

Automate Your Workflow. Get a real-time feed of all Sopharma AD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Sopharma AD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Sopharma AD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.